Reich Samuel J
- SEC CIK
- 0001394645
No open-market purchases or sales filed in the past year.
Current role at each company
- SABS SAB Biotherapeutics, Inc.CEOas of Feb 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Reich Samuel J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2023 (view filing) | Nov 29 | 1 day | Reich Samuel JExecutive Chairman | PPurchase | +11.0K | $0.89 | +$9.79K | +5.3%219.0K after | |
| Oct 15, 2021 (view filing) | Oct 14 | 1 day | Reich Samuel JCEO and CFO | PPurchase | +1.00K | $10.11 | +$10.1K | New position1.00K after |